Pirouette Pharma develops innovative healthcare solutions, focusing on advanced drug delivery systems and therapies to enhance patient care and improve lives.
Employees
9
Founded
2017
Company Stage
Seed
Investors
- Safar Partners
- Y Combinator
YC Batch
S21
Product Features & Capabilities
Emergency auto-injector for severe allergic reactions, potential for opioid overdose treatment, advanced drug delivery systems.
How much Pirouette Pharma raised
Community Round (not specified) - $6,049,106
Closing on March 13, 2024
Lead Investor: 3,898 investors, backed by Y Combinator, Safar Partners, Liquid 2 Ventures, Gaingels